期刊文献+

SAC重组腺相关病毒载体的构建及其对前列腺癌CAM移植瘤的抑制作用 被引量:1

Construction of a recombinant adeno-associated viral vector expressing SAC and its inhibition on CAM xenograft prostate cancer
原文传递
导出
摘要 目的构建携带NT4-SAC-HA2-TAT融合基因的重组腺相关病毒载体,并感染前列腺癌鸡胚绒毛尿囊膜(CAM)移植瘤,观察目的基因前列腺凋亡反应基因-4(par-4)选择性癌细胞凋亡结构域(SAC)的表达及其对CAM移植瘤的生长抑制作用。方法利用磷酸钙共沉淀法将包装质粒pAAV/Ad、腺病毒辅助质粒pFG140及重组穿梭质粒pSSCMV/NT4-SAC-HA2-TAT共转染293细胞,制备重组腺相关病毒(rAAV),斑点杂交法检测病毒滴度。取孵育9 d龄健康鸡胚,CAM接种前列腺癌细胞系PC-3细胞,建立前列腺癌的CAM移植瘤模型,接种3 d后挑选成瘤鸡胚随机分为3组:空白对照组(PBS),空病毒组(AAV)和重组病毒组(rAAV),观察瘤体生长情况,上述处理4 d后测量比较不同组移植瘤体积,并切片染色病理检查。免疫荧光法检测移植瘤中SAC融合肽的表达。结果酶切鉴定结果证实成功构建pSSCMV/NT4-SAC-HA2-TAT,斑点杂交法检测重组病毒滴度约为3.34×1010~3.34×1011cfu/mL。免疫荧光法证实SAC融合肽表达。移植瘤能在CAM上生长,可见瘤周围丰富毛细血管汇集,rAAV组瘤体显著缩小,病理HE染色可见瘤细胞局限及侵袭抑制。结论成功构建SAC重组腺相关病毒载体并感染前列腺癌CAM移植瘤,重组病毒表达分泌的SAC融合肽对前列腺癌CAM移植瘤具有诱导细胞凋亡、抑制肿瘤细胞侵袭性增殖等作用。 Objective To construct a recombinant adeno-associated virus expression plasmid containing a unique core domain of par-4 sufficient for selective apoptosis induction in cancer cells (SAC) and protein transduction domain TAT, and investigate the effect of the SAC on chick chorioallantoic membrane (CAM) xenograft prostate cancer. Methods Plasmids pAAV/Ad, pFG140 and pSSCMV/NT4-SAC-HA2-TAT were transfected into 293 cells by method of Ca3 ( P04 ) 2 to harvest rAAV-NT4-SAC-HA2-TAT whose titer was detected by dot blot. PC-3 cells were grafted onCAM in the 9~h day of the embryonic development to construct the CAM xenograft tumor model of prostate cancer. The growth of xenograft tumor and richness of CAM capillaries around tumor were observed and photographed. 3 days later, those chick embryos with tumor formation were randomly divided into three groups (the PBS group, the AAV group, and the rAAV group). The tumors of different groups were compared on the volume 4 days after the treatment and fixed with formalin for further analyzation using standard histopathology. The expression of SAC was detected with immuno- fluorescence method. Results Recombinant plasmid pSSCMV/NTa-SAC-HA2-TAT was successfully constructed con-firmed by restriction enzyme digestion. The viral titer was about 3.34×10^10-3.34×10^11cfu/mL detected by dot blot. The expression of SAC fusion peptide in the tumor tissue was detected by immune-fluorescence test. The xenograft tumor could grow on the CAM, and a mass of capillaries around the tumor were observed. Tumors in the rAAV group significantly shrank. The invasiveness of PC-3 cells was inhibited and the tumor cells distributions were limited under the microscope. Conclusion The xenograft tumor model of prostate cancer on CAM is established successfully. Fusion peptide of SAC plays a significant role in inhibiting the invasiveness and inducting the apoptosis of PC-3 cells.
出处 《山东大学学报(医学版)》 CAS 北大核心 2012年第7期41-45,49,共6页 Journal of Shandong University:Health Sciences
基金 山东大学科技发展计划(200815028)
关键词 前列腺凋亡反应基因-4选择性癌细胞凋亡结构域 重组腺相关病毒 鸡胚绒毛尿囊膜 雄激素非依赖性前列腺癌 移植瘤 基因治疗 Par-4-SAC Recombinant adeno-associated virus Chick chorioallantoic membrane Androgen-independentprostate cancer Xenograft tumor Gene therapy
  • 相关文献

参考文献14

  • 1Ahmed H. Promoter methylation in prostate cancer and its application for the early detection of prostate cancer using serum and urine samples[J].Biomark Cancer,2010,(02):17-33.
  • 2El-guendy N,Zhao Y,Gurumurthy S. Identification of a unique core domain of par-4 sufficient for selective apoptosis induction in cancer cells[J].Molecular and Cellular Biology,2003,(16):5516-5525.doi:10.1128/MCB.23.16.5516-5525.2003.
  • 3张士宝,刘庆勇,阮喜云,陈杰,张建军,李宗武,杨广笑,王全颖.NT_4-SAC-HA_2-TAT融合基因表达载体的构建及鉴定[J].山东大学学报(医学版),2009,47(6):15-19. 被引量:1
  • 4Kunzi-rapp K,Genze F,Kufer R. Chorioallantoic membrane assay:vascularized 3-dimensional cell culture system for human prostate cancer cells as an animal substitute model[J].The Journal of Urology,2001,(04):1502.doi:10.1016/S0022-5347(05)65820-X.
  • 5Balke M,Neumann A,Kersting C. Morphologic characterization of osteosarcoma growth on the chick chorioallantoic membrane[J].BMC Res Notes,2010.58.doi:10.1186/1756-0500-3-58.
  • 6Isaacs J T,Isaacs W B. Androgen receptor outwits prostate cancer drugs[J].Nature Medicine,2004,(01):26-27.doi:10.1158/0008-5472.CAN-09-0236.
  • 7Culmsee C,Zhu Y,Krieglstein J. Evidence for the involvement of Par-4 in ischemic neuron cell death[J].Journal of Cerebral Blood Flow and Metabolism,2001,(04):334-343.doi:10.1055/s-0030-1248262.
  • 8Duan,Guo Z,Mattson M P. Participation of par-4 in the degeneration of striatal neurons induced by metabolic compromise with 3-nitropropionic acid[J].Experimental Neurology,2000,(01):1-11.doi:10.1006/exnr.2000.7434.
  • 9Nalca A,Qiu SG,E1-Guendy N. Oncogenic Ras sensitizes cells to apoptosis by Par-4[J].Journal of Biological Chemistry,1999,(42):29976-29983.doi:10.1074/jbc.274.42.29976.
  • 10Gurumurthy S,Goswami A,Vasudevan K M. Phosphorylation of Par-4 by protein kinase A is critical for apoptosis[J].Molecular and Cellular Biology,2005,(03):1146-1161.doi:10.1128/MCB.25.3.1146-1161.2005.

二级参考文献10

  • 1杨宇,吴江,杨欣,胡林森.NT4-NAP融合基因原核表达载体的构建及在大肠杆菌中的表达[J].中华神经科杂志,2004,37(3):260-261. 被引量:17
  • 2Schayowitz A, Sabnis G, Vincent C O, et al. Synergistic effect of a novel antiandrogen, VN/124-1, and signal transduction inhibitors in prostate cancer progression to hormone independence in vitro[J]. Mol Cancer Ther, 2008, 7(1) : 121-132.
  • 3Ntais C, Polyearpou A, Tsatsonlis A, et al. Molecular epidemiology of prostate cancer: androgens and polymorphisma in androgen related genes [ J ]. Eur J Endocrinol, 2003, 149 (6) :469-477.
  • 4El-Guendy N, Rangnekar V M. Apoptosis by Par-4 in cancer and neurodegenerative diseases[J]. Cell Res, 2003, 283( 1): 51-66.
  • 5Affarel B, Luke M P, Gay F, et al. Targeted ablation of Par-4 reveals a cell type-specific susceptibility to apoptosis-inducing agents[ J]. Cancer Res, 2006, 66 : 3456-3462.
  • 6Gurumurthy S, Goswami A, Vasudevan K M, et al. Phosphorylation of Par-4 by protein kinase A is critical for apoptosis [J]. Mol Cell Biol, 2005, 25(3) : 1146-1161.
  • 7El-Guendy N, Zhao Y, Gurumurthy S, et al. Identification of a unique core domain of par-4 sufficient for selective apoptosis induction in cancer cells[J]. Mol Cell Biol, 2003, 23(16) : 5516-5525.
  • 8Ryu J, Han K, Park J, et al. Enhanced uptake of a heterologous protein with an HIV-1 Tat protein transduction domains (PTD) at both termini[J]. Mol Cells, 2003, 16(3) :385-391.
  • 9Franc B L, Mandl S J, Siprashvili Z, et al. Breaching biological barriers: Protein translocation domains as tools for molecular imaging and therapy[J]. Mol Imaging, 2003, 2(4):313-323.
  • 10阮喜云,毕建忠,刘庆勇,张士宝,杨广笑,王全颍.hTRX-PR39融合基因cDNA克隆的构建及鉴定[J].山东大学学报(医学版),2009,47(3):30-34. 被引量:2

共引文献1

同被引文献17

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部